Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 
This study describes patterns and perceptions of fentanyl exposure among opioid users in Rhode Island.
Original research | 2017
Evidence base, Harm reduction, Safer supply, Illegal drugs
This study reports the outcomes of the B-Team (Buprenorphine-Team), a hospitalist-led interprofessional program created to identify hospitalized patients with OUD, initiate buprenorphine in the inpati
Original research | 2021
Clinical guidance, Evidence base, Wrap-around services, About prescribers, Outcomes, Substitution/OAT, Transitions in care/treatment, Hospitals
Assess whether Insite facilitated drug use and/or delayed entry into drug treatment
Original research | 2010
Illegal drugs, Indigenous, Transitions in care/treatment, SCS/OPS
This analysis provides an overview of the pharmacokinetic profile of FBT based on pooled data from nine pharmacokinetic studies.
Original research | 2012
About prescribers, Chronic pain
Commentary | 2022
Overdose, Advocacy, Legal system/law enforcement, Illegal drugs, Stigma, Mental health

Identify key barriers and facilitators to participant engagement with the hydromorphone tablet program.

Original research | 2020
Safer supply, Barriers and enablers, Injecting drugs
Socioeconomic factors are underexplored potential determinants of opioid OD.
Original research | 2021
Overdose, Policy/Regulatory, Equity, Social services, Outcomes, Poverty, Legal system/law enforcement
Look at drivers of the US opioid crisis
Commentary | 2019
Mortality, Policy/Regulatory, Illegal drugs, Drug checking, SCS/OPS
Commentary | 2018
Overdose, Advocacy
Examines whether the provision of regulated and quality-controlled heroin to users in specified doses would reduce heroin overdose rates
Commentary | 2014
Overdose, Policy/Regulatory, Safer supply

Response to responses on Bonn et al "Addressing the Syndemic…"

Letter | 2021
Policy/Regulatory, Safer supply, Advocacy, Illegal drugs
To examine characteristics of first-time methadone and buprenorphine clients and factors associated with risk of leaving first treatment in New South Wales (NSW), Australia.
Original research | 2015
Harm reduction, About prescribers, Outcomes, Crime, Legal system/law enforcement, Substitution/OAT
This systematic review aims to describe and summarise psychometric properties, feasibility and clinical utility of the available tools for measuring empowerment in psychosocially vulnerable population
Lit review | 2021
Equity, Peer/PWLLE program involvement, Social benefits
Report | 2021
Overdose, Harm reduction, Policy/Regulatory, Equity, Advocacy, About prescribers, About PWUD, Legal system/law enforcement, Illegal drugs, Youth, Chronic pain, Workplace, 2SLGBTQI+, Indigenous, Sex/Gender , Mental health
Slide deck | 2019
Clinical guidance, Harm reduction, About prescribers, Illegal drugs, Hospitals
Commentary | 2021
Withdrawal, Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Stigma, Hospitals
Newsletter | 2019
Hesitancy of prescribers , Safer supply, About prescribers, Injecting drugs
Slide deck | 2021
Policy/Regulatory, Decriminalization/legalization, Advocacy, About PWUD

Refine Your Search

Keywords
Format
Region